Sawai Group Holdings Co., Ltd. (TYO:4887)

Market Cap	234.77B
Revenue (ttm)	184.01B
Net Income (ttm)	25.65B
Shares Out	115.45M
EPS (ttm)	164.82
PE Ratio	23.47
Forward PE	10.83
Dividend	54.00 (2.66%)
Ex-Dividend Date	Mar 28, 2025

Volume	520,600
Average Volume	437,425
Open	2,035.50
Previous Close	2,056.00
Day's Range	2,025.50 - 2,064.00
52-Week Range	1,794.50 - 2,308.67
Beta	-0.01
RSI	56.01
Earnings Date	May 14, 2025

About Sawai Group Holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 3,482
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4887

Financial Performance

In 2023, Sawai Group Holdings's revenue was 176.86 billion, a decrease of -11.72% compared to the previous year's 200.34 billion. Earnings were 13.70 billion, an increase of 8.12%.